Literature DB >> 26556394

The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator.

Daniela Xhindoli1, Sabrina Pacor1, Monica Benincasa1, Marco Scocchi1, Renato Gennaro1, Alessandro Tossi2.   

Abstract

The human cathelicidin hCAP18/LL-37 has become a paradigm for the pleiotropic roles of peptides in host defence. It has a remarkably wide functional repertoire that includes direct antimicrobial activities against various types of microorganisms, the role of 'alarmin' that helps to orchestrate the immune response to infection, the capacity to locally modulate inflammation both enhancing it to aid in combating infection and limiting it to prevent damage to infected tissues, the promotion of angiogenesis and wound healing, and possibly also the elimination of abnormal cells. LL-37 manages to carry out all its reported activities with a small and simple, amphipathic, helical structure. In this review we consider how different aspects of its primary and secondary structures, as well as its marked tendency to form oligomers under physiological solution conditions and then bind to molecular surfaces as such, explain some of its cytotoxic and immunomodulatory effects. We consider its modes of interaction with bacterial membranes and capacity to act as a pore-forming toxin directed by our organism against bacterial cells, contrasting this with the mode of action of related peptides from other species. We also consider its different membrane-dependent effects on our own cells, which underlie many of its other activities in host defence. This article is part of a Special Issue entitled: Pore-Forming Toxins edited by Mauro Dalla Serra and Franco Gambale.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptide; CRAMP; Cathelicidin; Host defence peptide; Innate immunity; LL-37; hCAP-18

Mesh:

Substances:

Year:  2015        PMID: 26556394     DOI: 10.1016/j.bbamem.2015.11.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  92 in total

Review 1.  Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects.

Authors:  Amy A Baxter; Fung T Lay; Ivan K H Poon; Marc Kvansakul; Mark D Hulett
Journal:  Cell Mol Life Sci       Date:  2017-08-02       Impact factor: 9.261

2.  Disrupting Membrane Adaptation Restores In Vivo Efficacy of Antibiotics Against Multidrug-Resistant Enterococci and Potentiates Killing by Human Neutrophils.

Authors:  Sandra Rincon; Diana Panesso; William R Miller; Kavindra V Singh; Melissa R Cruz; Ayesha Khan; An Q Dinh; Lorena Diaz; Rafael Rios; Yousif Shamoo; Jinnethe Reyes; Truc T Tran; Danielle A Garsin; Cesar A Arias
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

Review 3.  Rediscovery of antimicrobial peptides as therapeutic agents.

Authors:  Minkyung Ryu; Jaeyeong Park; Ji-Hyun Yeom; Minju Joo; Kangseok Lee
Journal:  J Microbiol       Date:  2021-02-01       Impact factor: 3.422

4.  Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.

Authors:  Takahiro Yanagisawa; Masakazu Ishii; Manami Takahashi; Kei Fujishima; Masahiro Nishimura
Journal:  Mol Biol Rep       Date:  2020-09-04       Impact factor: 2.316

5.  Orai1-Mediated Antimicrobial Secretion from Pancreatic Acini Shapes the Gut Microbiome and Regulates Gut Innate Immunity.

Authors:  Malini Ahuja; Daniella M Schwartz; Mayank Tandon; Aran Son; Mei Zeng; William Swaim; Michael Eckhaus; Victoria Hoffman; Yiyuan Cui; Bo Xiao; Paul F Worley; Shmuel Muallem
Journal:  Cell Metab       Date:  2017-03-07       Impact factor: 27.287

6.  Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.

Authors:  Francisco R Fields; Giorgia Manzo; Charlotte K Hind; Jeshina Janardhanan; Ilona P Foik; Phoebe Do Carmo Silva; Rashna D Balsara; Melanie Clifford; Henry M Vu; Jessica N Ross; Veronica R Kalwajtys; Alejandro J Gonzalez; Tam T Bui; Victoria A Ploplis; Francis J Castellino; Albert Siryaporn; Mayland Chang; J Mark Sutton; A James Mason; Shaun Lee
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

7.  Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration.

Authors:  Fern Findlay; Jan Pohl; Pavel Svoboda; Priyanka Shakamuri; Kevin McLean; Neil F Inglis; Lorna Proudfoot; Peter G Barlow
Journal:  J Immunol       Date:  2017-08-16       Impact factor: 5.422

8.  Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae.

Authors:  Wongsakorn Kiattiburut; Ruina Zhi; Seung Gee Lee; Alexander C Foo; Duane R Hickling; Jeffrey W Keillor; Natalie K Goto; Weihua Li; Wayne Conlan; Jonathan B Angel; Guangshun Wang; Nongnuj Tanphaichitr
Journal:  Hum Reprod       Date:  2018-12-01       Impact factor: 6.918

9.  Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins.

Authors:  Sunita Gulati; Ian C Schoenhofen; Theresa Lindhout-Djukic; Lisa A Lewis; Iesha Y Moustafa; Sudeshna Saha; Bo Zheng; Nancy Nowak; Peter A Rice; Ajit Varki; Sanjay Ram
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

10.  The Human Cathelicidin Antimicrobial Peptide LL-37 Promotes the Growth of the Pulmonary Pathogen Aspergillus fumigatus.

Authors:  Gerard Sheehan; Gudmundur Bergsson; Noel G McElvaney; Emer P Reeves; Kevin Kavanagh
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.